Therapeutic advances in hematology

Keyphrases

Publications

volume 15, 2024

Yanni Xie, Gaohui Yang, Lin Pan, Zhaoping Gan, Yumei Huang, Yong-Rong Lai, Rongrong Liu
Development of a nomogram to predict the risk of secondary failure of platelet recovery in patients with β-thalassemia major after hematopoietic stem cell transplantation: a retrospective study. Therapeutic advances in hematology 15 (2024)
Shihui Yuan, Ying Chen, Huasheng Liu
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma. Therapeutic advances in hematology 15 (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A Fox
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine. Therapeutic advances in hematology 15 (2024)
Margareth Castro Ozelo, Cedric Hermans, Manuel D Carcao, Philippe Gautier, Joan Gu, Randy Guerra, Leilei Tang, Kate Khair
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study. Therapeutic advances in hematology 15 (2024)
Jia-Nan Li, Yi-Jun Chen, Zhong Fan, Qiao-Ru Li, Liu-Hua Liao, Zhi-Yong Ke, Yu Li, Li-Na Wang, Cui-Yun Yang, Xue-Qun Luo, Yan-Lai Tang, Xiao-Li Zhang, Li-Bin Huang
Intensive chemotherapy with dual induction and ALL-like consolidation for childhood acute myeloid leukemia: a respective report from multiple centers in China. Therapeutic advances in hematology 15 (2024)
Benjamin J Lee
Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study. Therapeutic advances in hematology 15 (2024)
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, Junichi Tsuchiya, Tomohiro Kubo, SungGi Chi, Yosuke Minami
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy. Therapeutic advances in hematology 15 (2024)
Jean-Matthieu L'Orphelin
An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sézary syndrome: a case report. Therapeutic advances in hematology 15 (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A Fox
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine. Therapeutic advances in hematology 15 (2024)
Juan Carlos Caballero-Berrocal, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campelo
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. Therapeutic advances in hematology 15 (2024)
Yan Li, Pu Kuang, Huanling Zhu, Ling Pan, Tian Dong, Ting Lin, Yu Chen, Yunfan Yang
Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors. Therapeutic advances in hematology 15 (2024)
Jia-Nan Li, Yi-Jun Chen, Zhong Fan, Qiao-Ru Li, Liu-Hua Liao, Zhi-Yong Ke, Yu Li, Li-Na Wang, Cui-Yun Yang, Xue-Qun Luo, Yan-Lai Tang, Xiao-Li Zhang, Li-Bin Huang
Intensive chemotherapy with dual induction and ALL-like consolidation for childhood acute myeloid leukemia: a respective report from multiple centers in China. Therapeutic advances in hematology 15 (2024)
Yan Li, Pu Kuang, Huanling Zhu, Ling Pan, Tian Dong, Ting Lin, Yu Chen, Yunfan Yang
Successful maintenance of a sustained molecular response in CML patients receiving low-dose tyrosine kinase inhibitors. Therapeutic advances in hematology 15 (2024)
Benjamin J Lee
Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study. Therapeutic advances in hematology 15 (2024)
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, Junichi Tsuchiya, Tomohiro Kubo, SungGi Chi, Yosuke Minami
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy. Therapeutic advances in hematology 15 (2024)
Xinping Song, Jing Lao, Lulu Wang, Sixi Liu
Research advances on short-chain fatty acids in gastrointestinal acute graft- versus -host disease. Therapeutic advances in hematology 15 (2024)
Anna Klukowska, Robert F Sidonio, Guy Young, Maria Elisa Mancuso, Maria Teresa Alvarez-Roman, Neha Bhatnagar, Martina Jansen, Sigurd Knaub
Simoctocog alfa (Nuwiq ® ) in children: early steps in life's journey for people with severe hemophilia A. Therapeutic advances in hematology 15 (2024)
Jean-Matthieu L'Orphelin
An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sézary syndrome: a case report. Therapeutic advances in hematology 15 (2024)
Shihui Yuan, Ying Chen, Huasheng Liu
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma. Therapeutic advances in hematology 15 (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Yuehong Qin, Yu Wang, Yujiao Zhang, Yingying Jiao, Jieyu Ye
Avatrombopag for the salvage treatment of platelet transfusion refractoriness. Therapeutic advances in hematology 15 (2024)
Yi Liu, Xuejiao Yin, Dan Xu, Yunfei Lv, Li Zhu, Min Yang, Qiumei Yao, Jie Jin, Li Huang, Haitao Meng, Liang-Shun You
When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China. Therapeutic advances in hematology 15 (2024)
Yi Liu, Xuejiao Yin, Dan Xu, Yunfei Lv, Li Zhu, Min Yang, Qiumei Yao, Jie Jin, Li Huang, Haitao Meng, Liang-Shun You
When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China. Therapeutic advances in hematology 15 (2024)
Jiaying Wu, Delian Zhou, Xiaojian Zhu, Yicheng Zhang, Yi Xiao
Updates of primary central nervous system lymphoma. Therapeutic advances in hematology 15 (2024)
Qianlei Huang, Ranran Zhao, Lu Xu, Xinbao Hao, Shi Tao
Treatment of multiple myeloma with selinexor: a review. Therapeutic advances in hematology 15 (2024)
Jing Xu, Yixin Yan, Siwen Zong, Wencan Ye, Jifu Zheng, Chao Min, Qingming Wang, Zhenjiang Li
Rapid and sustained response to luspatercept and eltrombopag combined treatment in one case of clonal cytopenias of undetermined significance with prior failure to cyclosporin and androgen therapy: a case report. Therapeutic advances in hematology 15 (2024)
Jiaying Wu, Delian Zhou, Xiaojian Zhu, Yicheng Zhang, Yi Xiao
Updates of primary central nervous system lymphoma. Therapeutic advances in hematology 15 (2024)
Jing Xu, Yixin Yan, Siwen Zong, Wencan Ye, Jifu Zheng, Chao Min, Qingming Wang, Zhenjiang Li
Rapid and sustained response to luspatercept and eltrombopag combined treatment in one case of clonal cytopenias of undetermined significance with prior failure to cyclosporin and androgen therapy: a case report. Therapeutic advances in hematology 15 (2024)
Chen Gong, Ying Liu, Ming-Zhi Zhang
A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. Therapeutic advances in hematology 15 (2024)
Chen Gong, Ying Liu, Ming-Zhi Zhang
A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. Therapeutic advances in hematology 15 (2024)
Anna Klukowska, Robert F Sidonio, Guy Young, Maria Elisa Mancuso, Maria Teresa Alvarez-Roman, Neha Bhatnagar, Martina Jansen, Sigurd Knaub
Simoctocog alfa (Nuwiq ® ) in children: early steps in life's journey for people with severe hemophilia A. Therapeutic advances in hematology 15 (2024)
Chenyu Zha, Jialu Song, Ming Wan, Xiao Lin, Xiaolin He, Ming Wu, Rui Huang
Recent advances in CAR-T therapy for the treatment of acute myeloid leukemia. Therapeutic advances in hematology 15 (2024)
Chenggong Li, Xindi Wang, Jia Xu, Jiachen Liu, Heng Mei
Treatment of multiple myeloma: What is the impact on T-cell function? Therapeutic advances in hematology 15 (2024)
Chenggong Li, Xindi Wang, Jia Xu, Jiachen Liu, Heng Mei
Treatment of multiple myeloma: What is the impact on T-cell function? Therapeutic advances in hematology 15 (2024)
Benjamin J Lee
Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study. Therapeutic advances in hematology 15 (2024)
Yanni Xie, Gaohui Yang, Lin Pan, Zhaoping Gan, Yumei Huang, Yong-Rong Lai, Rongrong Liu
Development of a nomogram to predict the risk of secondary failure of platelet recovery in patients with β-thalassemia major after hematopoietic stem cell transplantation: a retrospective study. Therapeutic advances in hematology 15 (2024)
Xinping Song, Jing Lao, Lulu Wang, Sixi Liu
Research advances on short-chain fatty acids in gastrointestinal acute graft- versus -host disease. Therapeutic advances in hematology 15 (2024)
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, Junichi Tsuchiya, Tomohiro Kubo, SungGi Chi, Yosuke Minami
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy. Therapeutic advances in hematology 15 (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Nicola R Mason, Hilary Cahill, Yonatan Diamond, Karen McCleary, Rishi S Kotecha, Glenn M Marshall, Marion K Mateos
Down syndrome-associated leukaemias: current evidence and challenges. Therapeutic advances in hematology 15 (2024)
Yuehong Qin, Yu Wang, Yujiao Zhang, Yingying Jiao, Jieyu Ye
Avatrombopag for the salvage treatment of platelet transfusion refractoriness. Therapeutic advances in hematology 15 (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Nina Frischhut, Van Anh Nguyen
A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab. Therapeutic advances in hematology 15 (2024)
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A Fox
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine. Therapeutic advances in hematology 15 (2024)
Tim Kong, Nicole Gaudin, Karyn Gordon, Maggie J Cox, Amy W Zhou, Stephen T Oh
A phase I trial of pevonedistat in combination with ruxolitinib for the treatment of myelofibrosis. Therapeutic advances in hematology 15 (2024)
Margareth Castro Ozelo, Cedric Hermans, Manuel D Carcao, Philippe Gautier, Joan Gu, Randy Guerra, Leilei Tang, Kate Khair
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study. Therapeutic advances in hematology 15 (2024)
Qianlei Huang, Ranran Zhao, Lu Xu, Xinbao Hao, Shi Tao
Treatment of multiple myeloma with selinexor: a review. Therapeutic advances in hematology 15 (2024)
Juan Carlos Caballero-Berrocal, Julio Dávila, María López-Pavía, Esperanza Such, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Jesús María Hernández Sánchez, Helena Pomares, Mercedes Sánchez Barba, María Abáigar, Bernardo González, Brayan Merchán, Reyes Sancho-Tello, Marta Callejas, Carolina Muñoz-Novas, Carlos Cerveró, Guillermo Sanz, Jesús María Hernández Rivas, María Díez Campelo
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. Therapeutic advances in hematology 15 (2024)